BACKGROUND: Type 2 diabetes mellitus (DM) is a known systemic risk factor for periodontitis. An increased expression of CD44 has been suggested in type 2 diabetics and periodontitis patients. OBJECTIVES: The present study aimed to assess the expression of CD44 antigen in patients with chronic periodontitis (CP) and type 2 DM in a South Indian urban population. Additionally, the relationships between the expression of CD44 antigen in gingival tissues, periodontal clinical parameters, and the random blood sugar (RBS) and glycated hemoglobin (HbA1c) levels were assessed. MATERIAL AND METHODS: A total of 63 subjects were divided into 3 groups: systemically and periodontally healthy controls (group H); CP patients, otherwise healthy (group CP); and CP patients with type 2 DM (group CP+DM). Periodontal parameters were recorded for all groups, and additionally the RBS and HbA1c levels for group CP+DM. Gingival tissue samples were obtained and subjected to immunohistochemical analysis for CD44. RESULTS: The expression of CD44 was significantly higher in the diseased groups. Epithelial CD44 expression was significantly stronger in group CP+DM as compared to groups CP and H (p < 0.001), whereas connective tissue CD44 expression was similar in groups CP and CP+DM (p = 0.657). Furthermore, an inverse relationship was observed between blood glucose parameters and CD44 expression in the epithelium and connective tissue. CONCLUSIONS: The expression of CD44 increased with the severity of periodontal disease. Additionally, glycemic control in patients with CP and type 2 DM had an impact on CD44 expression. Our findings indicate a possible destructive role of CD44 in the pathogenesis of periodontal diseases in individuals with type 2 DM.
Chronic Periodontitis , Diabetes Mellitus, Type 2 , Gingiva , Glycated Hemoglobin , Hyaluronan Receptors , Humans , Hyaluronan Receptors/metabolism , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/complications , Male , Female , Chronic Periodontitis/metabolism , Adult , Glycated Hemoglobin/metabolism , Middle Aged , Gingiva/metabolism , Immunohistochemistry , Blood Glucose/metabolism , Periodontal Index , Case-Control Studies , India
Local Anesthetics are used clinically for anesthesia and analgesia either following surgery or for management of acute and chronic pain conditions. Liposomal Encapsulation aids in improved delivery at the tissue level. This paper deals with formulation and characterization of Gadus morhua derived liposome encapsulated Lidocaine nanoparticles. Materials and methods: Water Soluble liposomes were synthesized and encapsulated to lidocaine. The prepared liposomes were assessed using field emission scanning electron microscope, TEM, FTIR, Zetapotential, Anti-inflammatory property and Drug release kinetics. Results: The structural and morphological characters of the conjugated liposomes were studied using SEM & TEM, surface charge Zetapotential. The cumulative drug release was studied for up to 72 h in which more than 70 % of the drug was released from the Liposomal nanoparticles. FTIR revealed similar functional groups like the control. Stability of the drug was superior than the control. Conclusion: Liposomal conjugation delays the drug release which can be used in slow release applications. Improving the drug release kinetics can be advantageous in many chronic pain conditions. Additionally, the changes in the functional groups can also aid in reduction or masking of bitterness.
